Stewart Murray has filed 8 insider transactions across 3 companies since January 2023.
Most recent transaction: a grant/award of 110000 shares of X4 Pharmaceuticals, Inc ($XFOR) on January 01, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2026 | X4 Pharmaceuticals, Inc | $XFOR | Stewart Murray | Director | A | Stock Option (right to buy) | 110000 | $0.00 | 0.0000 | 43,272,773 | 0.00% | 0.25% |
| June 9, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Stewart Murray | Director | A | Common Stock | 1500 | $0.00 | 7,883.0000 | 201,062,211 | 23.50% | 0.00% |
| March 17, 2025 | Camp4 Therapeutics Corp | $CAMP | Stewart Murray | Director | A | Stock Option (Right to Buy) | 17787 | $0.00 | 17,787.0000 | 20,161,072 | 9999.99% | 0.09% |
| June 10, 2024 | X4 Pharmaceuticals, Inc | $XFOR | Stewart Murray | Director | A | Common Stock | 45000 | $0.00 | 191,504.0000 | 177,812,480 | 30.72% | 0.03% |
| Aug. 9, 2023 | X4 Pharmaceuticals, Inc | $XFOR | Stewart Murray | Interim Chief Medical Officer | A | Common Stock | 269893 | $0.00 | 276,560.0000 | 63,525,845 | 4048.19% | 0.42% |
| Aug. 10, 2023 | X4 Pharmaceuticals, Inc | $XFOR | Stewart Murray | Interim Chief Medical Officer | S | Common Stock | 130056 | $1.06 | 146,504.0000 | 63,525,845 | 47.03% | 0.20% |
| Jan. 9, 2023 | AMARIN CORP PLCUK | $AMRN | Stewart Murray | Not found | A | Stock Option (Right to Buy) | 223560 | $0.00 | 223,560.0000 | 408,824,093 | 9999.99% | 0.05% |
| Jan. 9, 2023 | AMARIN CORP PLCUK | $AMRN | Stewart Murray | Not found | A | Restricted Stock Units | 182433 | $0.00 | 182,433.0000 | 408,824,093 | 9999.99% | 0.04% |